8
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Patent Update Central & Peripheral Nervous System: Agents for the treatment of neurodegenerative diseases: part 2

Pages 343-378 | Published online: 03 Mar 2008

References to Primarv Literaturess

  • BAUDY RB: Gun'. Opin. Thera. Patents (1993) 3(12):1763–1786.
  • GOODMAN et al.: Mol. Pharmacol. (1982) 21:329–335.
  • 21?&,chem../ (1982) 208:809–817
  • Mol. Pharmacol. (1990) 38:370.
  • CAMERON et al.: Quart. J. Exp. Phys. (1989) 74:917–926.
  • FORDA: Brain Res. (1985) 22:55–65.
  • Mol. Pharmacol. (1979) 16:579.
  • CHANG, LOTH: Proc. Natl. Acad. Sci. USA (1986) 83:4923–4926.
  • Proc. Natl. Acad. Sci. USA (1980) 77:6917–6921.
  • J. Neurochem. (1981) 37:483–490.
  • FORNO et al: J. Pharmacol. Exp. Ther. 261:1056.
  • IAI: Gut (1964) 5:327–341.
  • DENERIS ES et al.: TIPS (1991) 12:34–40.
  • WHITEHOUSE P.T et al.: Neurology (1988) 38:720–723.
  • WHITEHOUSE PJ et al.: Arch. Neurol. (1988) 45:722–724.
  • PERRY EK et al.: J. Neurol. Neurosurg. Psychiatry (1985) 48:413–421.
  • FLYNN DD et al.: J. Neurochem. (1986) 47:1948–1954.
  • NORDBERG A eta!: Neurosci. Lett. (1986) 72:115–119.
  • QUIRON R et al.: Can. J. Neurol. Sci. (1986) 13:503–510.
  • COYLE JT et al.: Brain Res. (1986) 371:146–151.
  • ARAUJO DM et aL: J. Neurochem. (1988) 50:1914–1923.
  • DESARNO P et al.: Fed. Proc. (1988) 2:364.
  • GIACOBINI E et al.: In: The Cholinergic Receptor System in the Frontal Lobe of Alzheimer's Patients (1988). Springer, pp 367–378. NORDBERG A et al.: Neurosci Lett (1988) 88:317-321. LONDON ED et al: Neurochem. Res. (1989) 14:745-750. ICELLAR KJ et al.: In: Nicotine psychopharmacology: molecu-lar, cellular, and behavioral aspects (1990). Oxford University Press, pp 341–373.
  • SUGAYA K et al: J. Neurosci. Res. (1990) 27:349–359.
  • RINNE JO: Brain Res. (1991) 54:167–170.
  • SCHROOEDER H et al.: Neurobiol. Aging. (1991) 12:259–262.
  • VAN DUIJN CN et al.: BM J (1991) 302:1491–1494.
  • JONES GMM et al.: In: Pharmacological Interventions on Central Cholinergic Mechanisms in Senile Dementia (AD) (1989). Zucker-Schwerdt Verlag (San Francisco), pp 89–96.
  • WARBURTON DM: Clinical Neutopharmacology (1990) 13(2):579–580.
  • NEWHOUSE PA et al.: AmJ. Psychiat. (1986) 143:1494–1495.
  • NEWHOUSE PA et al.: Pharmacologist (1988) 30:A188 (127.6).
  • NEWHOUSE PA et al.: Psychopharmacology (1988) 95:171–175.
  • NEWHOUSE PA et al.: Psychoneuroendocrinology (1991) 15:471–484.
  • APPEL S: In: Brain Neurotransmitters and Receptors in Aging and Age-related Disorders (1981). Raven Press (New York), pp 203–207. GROSSBERG GT eta/. iklar (1980 37819–822 GRAVES AB et al.: Int. J. Epid. (1991) 20(2):548–557. BARCLAY LL et al.: AD and Assoc. Disorders (1988) 2:172. SHLAT SL etal: Neurology (1987) 37:1630-1633. ISHIKAWA A et al.: in: Therapeutic Aspects of AD and PD (1991). Plenum Press (New York), Vol 2, pp 187–195. ISHIKAWA A et al: Neurol Med. (1985) 23:562-568. SCHWARTZ RD et al.: Science (1983) 220:214-216. SCHWARTZ RD et al.: J. Neurochem. (1985) 45:427-433. ROWELL PP et al.: J. Neurochem. (1990) 55:2105-2110. FIERTZMAN C et al.: Am .J. Industrial Med. (1990) 17:349-355. BAUMANN RJ et al.: Neurology (1980) 30:839-843. GOLBE LI et al.: Neurology (1986) 43:774-778. KONDO K: Advances in Neurology (1986). Vol. 45. Raven Press (New York) pp 289–293. CAZZATO G et al: Riv. Neurol. (1985) 55:79-87. HIRAYAMA T: Japan Ministry of Health & Welfare (1985) KONDO K: Adv. Neurol (1984) 40:345-351. WARD CD et al.: Neurology (1983) 33:815-824. BARBEAU A et al.: Can.J. Neurol. Sci. (1982) 9:53-60. HAACK DG et al.: Am. J. Epidemiol. (1981) 114:191-200. MAR!fILA RJ et al.: Acta. Neurol. Scand. (1980) 62:322-325.DOLL R et at: BMJ (1975) 25:1525-1536. ANSARI ICA et aL: J. Chron. Dis. (1975) 28:493-497. KESSLER II: Am. J. Epidemiol. (1972) 96:242-254. KESSLER II et al.: Am. J. Epidemiol. (1971) 94:16-25. NEFZGER MD et al.: Am. J. Epidemiol. (1968) 88:149-158. HAMMOND EC: US Depart. of Health, Nat. Cancer Inst. Monograph 19 (1966). KAHN HA: US Depart. ofHealth . Nat. Cancer Inst. Monograph 19 (1966). BARON JA: Neurology (1986) 36:1490–1496.
  • ISHIKAWA A et al.: AD and PD Di's. Abstr. (1989) Kyoto, p.137.
  • DAMSMA G et al.: Neurosci. Lett. (1988) 89:349–354.
  • MARKS MJ et al.:J. Pharmacol. Exp. Ther. (1983) 226:817–825.
  • MARKSMJ et al :J. Pharmacol. Exp. Ther. (1985) 235:619–628.
  • KSIR C et al.: Neuropharmacology (1985) 24:527–531.
  • KSIR C et al: Psychopharmacology (1987) 92:25–29.
  • BENWEU et al.: Neurochem (1988) 50:1243.
  • LAPCHAK et al.: Neutochem (1989) 52:483.
  • WEONNACOTF S eta!: In: Progress in Brain Research (1989). Elsevier, pp 157–163.
  • ROWELL PP: Adv. Behav. Biol. (1987) 31:191–208.
  • CREGAN E et al.: Soc. Neurosci. Abstr. (1989) 15:731.
  • BUCCAFUSCO JJ et al.: Neurobiol. Aging (1991) 12:233–238.
  • TILSON HA et al.: Brain Res. (1988) 438:83–94.
  • DECKER MW etal.: Soc. Neurosci. Abstr. (1991) 17:1235.
  • SJAK-SHIE NN et al.: In: Cholinergic Basis for Alzheimer Therapy 0991). Birkhoauser Verlag, pp 379–385.
  • HODGES H et aL: Neuroscience (1991) 45:609–623.
  • HODGES H et al.: In: Effects of Nicotine on Biological Systems (1991). Birkhoauser Verlag, pp 389–399.
  • HODGES H et at: In: The Biology of Nicotine: current research issues (1992). Raven Press, pp 157–182.
  • SASAKI H et al.: Pharmacol. Biochem. Behav. (1991) 38:921–925.
  • SAHAKIAN B etal.: Br. J. Psychiatry (1989) 154:797–800.
  • WEST R: Psychopharmacology (1992) 108(4):408–410.
  • ROBINSON JH etal.: Psychopharmacology (1992) 108(4)411–416.
  • ROMANO etal.: Science (1980) 210:647–650.
  • HANSCH et al: J. Med. Chem. (1968) 11:1.
  • NAGY et al.: J. Neurochem. (1984) 43:1114–1123.
  • MARKS etal.: Mol. Pharmacol. (1986) 30:427–436.
  • NICKOLSON etal.: Drug Dev. Res. (1990) 19:285–300.
  • Naunyn Schmied. Arch. Pharmacol. (1982) 312:48.
  • BIRDSALL etal.: Proc. Roy. Soc. London (1980) 207:1
  • Eur. J. Pharmacol. (1986) 123:133.
  • ELLMAN etal.: Biochem. Pharmacol. (1961) 7:88.
  • JOHNSON etal.: Anal. Biochem. (1975) 64:229.
  • Clin. Chim. Acta (1981) 115:163–170.
  • WALTERS, ROTH: Naunyn Schmiedeberg's Arch . Pharmacol. (1976) 296:5–14.
  • J. Pharmacol. Exp. Therap. (1984) 229:706–711.

References to patent literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.